Medindia

X

Indian Researcher Comes Up With Strategy to Combat Drug-Resistant Bacteria

by Bidita Debnath on  November 13, 2013 at 6:28 PM Research News   - G J E 4
Rahul Kohli, an Indian origin scientist is among the winners of a GlaxoSmithKline (GSK) "academic drug hunter" competition, that will help fast track his lab's work in combating drug-resistant bacteria.
 Indian Researcher Comes Up With Strategy to Combat Drug-Resistant Bacteria
Indian Researcher Comes Up With Strategy to Combat Drug-Resistant Bacteria
Advertisement

With this new partnership, Rahul Kohli, MD, PhD, an assistant professor in the division of Infectious Diseases and department of Biochemistry and Biophysics at the Perelman School of Medicine at the University of Pennsylvania, and his lab can ramp up their efforts to discover drugs that stop the evolution in its tracks.

Advertisement
Rather than taking the conventional approach of modifying existing antibiotics to overcome resistance, Kohli's lab aims to target the very pathways by which bacteria adapt to antibiotics and evolve resistance.

Kohli's team, spearheaded by Charlie Mo, a graduate student in Biochemistry and Molecular Biophysics, will now have access to 1.8 million compounds kept in GSK's chemical library and their other drug discovery technologies.

Kohli said that the search is on to find a molecule that can disrupt the pathway that allows bacteria to acquire drug resistance, asserting that the hope is that such a molecule can make bacteria more sensitive to existing antibiotics or slow the acquisition to the resistance, both of which would be valuable in the clinic.

This is GSK's first Discovery Fast Track competition in North America, which is designed to translate academic research into starting points for new potential medicines. There were eight winners in total across the country, selected from an initial pool of over 140 applications across 17 therapeutic areas and from 70 different institutions.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All